Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Over the last 12 months, insiders at Nexalin Technology, Inc. have bought $27,674 and sold $0 worth of Nexalin Technology, Inc. stock.
On average, over the past 5 years, insiders at Nexalin Technology, Inc. have bought $27,674 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Owens David (Chief Medical Officer) — $27,674.
The last purchase of 2,000 shares for transaction amount of $6,080 was made by Owens David (Chief Medical Officer) on 2025‑02‑04.
2025-02-04 | Chief Medical Officer | 2,000 0.0154% | $3.04 | $6,080 | +12.38% | |||
2025-02-04 | Chief Medical Officer | 1,000 0.0076% | $2.98 | $2,980 | +12.38% | |||
2025-01-28 | Chief Medical Officer | 1,500 0.0126% | $2.70 | $4,050 | +21.21% | |||
2025-01-23 | Chief Medical Officer | 1,000 0.008% | $2.70 | $2,700 | +16.15% | |||
2025-01-13 | Chief Medical Officer | 2,000 0.0156% | $2.50 | $5,000 | +18.33% | |||
2024-10-28 | Chief Medical Officer | 500 0.0058% | $2.19 | $1,095 | 0.00% | |||
2024-08-13 | Chief Medical Officer | 1,000 0.0097% | $0.95 | $950 | 0.00% | |||
2024-06-28 | Chief Medical Officer | 1,000 0.0084% | $1.75 | $1,750 | 0.00% | |||
2024-06-18 | Chief Medical Officer | 1,619 0.0056% | $0.71 | $1,149 | +119.23% | |||
2024-06-10 | Chief Medical Officer | 3,000 0.0093% | $0.64 | $1,920 | +124.24% |
Increased Positions | 16 | +94.12% | 397,332 | +199.03% |
Decreased Positions | 7 | -41.18% | 80,661 | -40.41% |
New Positions | 14 | New | 362,670 | New |
Sold Out Positions | 5 | Sold Out | 75,794 | Sold Out |
Total Postitions | 26 | +52.94% | 516,301 | +158.63% |
Renaissance Technologies Llc | $300.00 | 0.79% | 102,900 | +102,900 | New | 2024-09-30 |
Geode Capital Management, Llc | $230.00 | 0.61% | 78,697 | +34,635 | +78.61% | 2024-09-30 |
Citadel Advisors Llc | $170.00 | 0.45% | 58,185 | +58,185 | New | 2024-09-30 |
Cvi Holdings, Llc | $162.00 | 0.43% | 55,462 | +55,462 | New | 2024-06-30 |
Susquehanna International Group, Llp | $124.00 | 0.33% | 42,383 | +42,383 | New | 2024-09-30 |
Vanguard Group Inc | $93.00 | 0.24% | 31,780 | 0 | 0% | 2024-09-30 |
Virtu Financial Llc | $68.00 | 0.18% | 23,447 | +23,447 | New | 2024-09-30 |
Two Sigma Securities, Llc | $67.00 | 0.18% | 23,045 | +23,045 | New | 2024-09-30 |
Drive Wealth Management, Llc | $58.00 | 0.15% | 20,000 | +20,000 | New | 2024-12-31 |
Atria Wealth Solutions, Inc. | $50.00 | 0.13% | 17,242 | 0 | 0% | 2024-12-31 |